Article by Bugworks featured in Antimicrobial Resistance campaign by Mediaplanet, distributed with Guardian UK
Bugworks chosen as number 5 within the top 10 innovative Biotech companies in India
Anand Anandkumar interviewed by Financial times for a special story on AMR
‘Antibiotic Resistance – video piece in the FT’, Bugworks is happy to have contributed to the narrative.
‘The world better be prepared for a silent pandemic” – article by Bugworks featured in the Guardian UK
Bugworks featured in an AMR Communique by Financial Times – October 2020
Dr. Anand is speaking at the ASPIRE Webinar series.
The Global Antibiotic Research and Development Partnership (GARDP) and Bugworks sign a MOU to Explore Antibiotic Development to Tackle Serious Bacterial Infections in High-Burden Countries.
Dr.Anand Anandkumar Co-Founder and CEO Bugworks Research Inc. addressing a panel on 'Global markets | Why we need to think global to tackle AMR’ - at the BIOCOM AG AMR 2020 conference
Bugworks’ CEO Anand Anandkumar PhD, speaks at the pre-conference webinar “The AMR community and its current state of play – Insights into recent facts and figures”, organised by BIOCOM. Here you can access the recording and the presentations slides (password: 2020webinar)
A Plan to Avert a ‘Superbug’ Pandemic
New $1 billion fund aims to steer antibiotic companies in tough market
UPCOMING WEBINAR: 9th July - 9:00-10:30 am CEST - Anand Anandkumar from Bugworks and Kamini Walia of ICMR - to speak in a webinar organised by GARDp, on the topic “The challenges and opportunities for antimicrobial R&D in low- and middle-income countries – India case study”.
Podcast - Leadership - From Now Into The Future - a dialog with Anand Anandkumar, Co-Founder and CEO, Bugworks
TERMSHEET Podcast: Swatting Superbugs with Anand Anandkumar of Bugworks
Dr. Santanu Datta (co-founder CSO Bugworks) Finding Genius Podcast interview is now available.
Biopharma startup Bugworks raises $7.5 million in fresh financing round
Biopharma startup Bugworks Research raises $7.5 mn in a fresh funding round. Megha Viswanath of CNBC-TV18 spoke with the CEO and Co-founder of Bugworks - Anand Anandkumar
Bugworks: breaking the U.S.-centric antimicrobial mold
Biopharma Start-Up Bugworks Raises $7.5 Mln In Fresh Financing
Bugworks raises $7.5M, will focus on pandemic preparedness
Bugworks Raises US$7.5M From a Global Investment Syndicate to Combat the Global Challenge Posed by Deadly Bacterial Superbugs
Bugworks invited as part of a global panel to present at - H20 Digital Dialogue Series with Dr Tedros Adhanom Ghebreyesus, World Health Organization
Developing next-gen drugs to fight superbugs
Bugworks CEO featured in this Times of India article – Retirement? These greypreneurs are just starting up
Participating in INNOVATION INDIA 2020 at JP Morgan Conference, San Francisco, USA on January 14, 2020
